Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Diet, High-Fat | 1 | 2019 | 161 | 0.73 | Why? |
| Extensively Drug-Resistant Tuberculosis | 1 | 2018 | 87 | 0.71 | Why? |
| Fatty Acids | 1 | 2019 | 238 | 0.70 | Why? |
| Acute Coronary Syndrome | 3 | 2020 | 2107 | 0.67 | Why? |
| Death, Sudden, Cardiac | 1 | 2020 | 522 | 0.59 | Why? |
| Mycobacterium tuberculosis | 4 | 2018 | 1164 | 0.58 | Why? |
| Cardiology | 6 | 2020 | 2873 | 0.57 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2018 | 1115 | 0.51 | Why? |
| Antitubercular Agents | 2 | 2018 | 775 | 0.49 | Why? |
| Cardiovascular System | 1 | 2020 | 750 | 0.46 | Why? |
| Cardiovascular Diseases | 4 | 2020 | 11497 | 0.46 | Why? |
| ST Elevation Myocardial Infarction | 4 | 2021 | 3051 | 0.44 | Why? |
| Heart Defects, Congenital | 1 | 2020 | 933 | 0.42 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.31 | Why? |
| India | 12 | 2021 | 11875 | 0.30 | Why? |
| Non-ST Elevated Myocardial Infarction | 2 | 2021 | 490 | 0.29 | Why? |
| Societies, Medical | 5 | 2020 | 6907 | 0.26 | Why? |
| Esophageal Stenosis | 1 | 2019 | 21 | 0.20 | Why? |
| Burns, Chemical | 1 | 2019 | 16 | 0.20 | Why? |
| Morbidity | 3 | 2020 | 1426 | 0.19 | Why? |
| Esophagoscopy | 1 | 2019 | 95 | 0.19 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.18 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.18 | Why? |
| Dilatation | 1 | 2019 | 181 | 0.18 | Why? |
| Rosacea | 1 | 2018 | 57 | 0.18 | Why? |
| Granuloma | 1 | 2018 | 88 | 0.17 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.17 | Why? |
| Percutaneous Coronary Intervention | 3 | 2021 | 3646 | 0.16 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.16 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2017 | 143 | 0.16 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.16 | Why? |
| Culicidae | 1 | 2018 | 239 | 0.16 | Why? |
| Cardiac Resynchronization Therapy | 1 | 2018 | 191 | 0.15 | Why? |
| Myocardial Reperfusion | 1 | 2017 | 168 | 0.15 | Why? |
| Disease Management | 3 | 2020 | 6841 | 0.15 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 669 | 0.15 | Why? |
| Electrocardiography | 2 | 2020 | 3957 | 0.14 | Why? |
| Facial Dermatoses | 1 | 2018 | 222 | 0.14 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.14 | Why? |
| Cardiac Imaging Techniques | 1 | 2017 | 357 | 0.14 | Why? |
| Myocardial Infarction | 2 | 2021 | 3361 | 0.14 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 449 | 0.14 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.14 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.13 | Why? |
| Program Development | 1 | 2020 | 1089 | 0.13 | Why? |
| Heart Failure | 3 | 2020 | 6638 | 0.13 | Why? |
| Ventricular Function, Left | 2 | 2021 | 1555 | 0.12 | Why? |
| Pacemaker, Artificial | 1 | 2017 | 431 | 0.12 | Why? |
| Microbial Sensitivity Tests | 2 | 2018 | 2886 | 0.12 | Why? |
| Stroke Volume | 2 | 2021 | 2153 | 0.12 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.12 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.11 | Why? |
| Program Evaluation | 1 | 2020 | 1929 | 0.11 | Why? |
| Defibrillators, Implantable | 1 | 2017 | 624 | 0.11 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.10 | Why? |
| Reconstructive Surgical Procedures | 1 | 2019 | 860 | 0.10 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.10 | Why? |
| Echocardiography | 2 | 2020 | 3661 | 0.09 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.09 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.09 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.09 | Why? |
| Humans | 24 | 2021 | 930598 | 0.09 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
| Tuberculosis, Pulmonary | 1 | 2017 | 1171 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.08 | Why? |
| Male | 15 | 2021 | 367725 | 0.08 | Why? |
| Female | 15 | 2021 | 380317 | 0.08 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Burnout, Professional | 1 | 2020 | 2489 | 0.07 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.06 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Thrombolytic Therapy | 1 | 2013 | 2218 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Esophagectomy | 1 | 2019 | 76 | 0.05 | Why? |
| DNA, Ribosomal Spacer | 1 | 2018 | 49 | 0.05 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Culex | 1 | 2018 | 66 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Developing Countries | 1 | 2013 | 4283 | 0.04 | Why? |
| Anopheles | 1 | 2018 | 89 | 0.04 | Why? |
| Disease Vectors | 1 | 2018 | 208 | 0.04 | Why? |
| Bacterial Typing Techniques | 1 | 2017 | 273 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Practice Patterns, Physicians' | 1 | 2013 | 4927 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2017 | 360 | 0.03 | Why? |
| Aedes | 1 | 2018 | 380 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.02 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.02 | Why? |
| Dyslipidemias | 1 | 2013 | 791 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Adult | 5 | 2020 | 244371 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.02 | Why? |
| Double-Blind Method | 1 | 2013 | 5988 | 0.01 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
| Aged | 4 | 2021 | 215776 | 0.01 | Why? |
| Evidence-Based Medicine | 1 | 2013 | 3228 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Length of Stay | 1 | 2013 | 11042 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Hypertension | 1 | 2013 | 8895 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.01 | Why? |
Yadav's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(202)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_